FDA Approves Over-the-Counter Sales of One Birth Control Pill. Now It’s Time To Approve All the Rest.
For decades, the American College of Obstetrics and Gynecology, the American Academy of Family Physicians, the American Medical Association, and the vast majority of practicing reproductive physicians have called for the Food and Drug Administration (FDA) to make hormonal contraceptives (e.g., birth control pills) available over the counter (OTC) to women of all ages.
When experts in the field who get paid for prescribing hormonal contraceptives nonetheless keep telling patients, “You don’t need to see me for this,” government regulators should take notice. Women can get birth control pills OTC in over 100 countries, formally or informally, around the globe. It’s time for them to be OTC in the “land of the free.”
The FDA might soon give access to a type of birth control pill that has been available only by prescription since 1973; in fact, today, an FDA panel voted unanimously to make birth control pills available OTC. But here’s a catch: women will only have access to one brand of one kind of birth control pill, a progestin-only pill sometimes called the “mini-pill.”
Unlike regular birth control pills, which contain two female hormones, estrogen and progesterone, the mini-pill doesn’t affect milk production in nursing mothers and is less likely to cause blood clots in women who smoke. To put this in perspective, pregnancy is more likely to cause clots than any pill to prevent it.
But, the mini-pill, while it may be slightly safer to use than other birth control pills, has drawbacks.
For example, the mini-pill only works if women take it at the same hour daily. If they take it more than three hours late, women must use another contraceptive for the rest of the month and start the cycle again. The same is true if they miss a day. With regular birth control pills, if women miss a day in the cycle, they can take two pills the following day.
While better than the status quo, the FDA shouldn’t restrict women’s OTC options to safer progestin-only pills, not to mention one progestin-only product. Unlike regulators in, say, Portugal, Brazil, or Mexico, the FDA doesn’t think American women can weigh the risks and benefits of various birth control pills and decide which is best for them—even if reproductive specialists believe they can.
Further mitigating drug-related side effects is that women may be more cautious than doctors in choosing the best drug for themselves. A 2006 study asked women to self-assess birth control pills. Ninety percent of the time, doctors agreed with their assessment, and 10 percent of the time, women were more conservative than doctors.
In 2013, the FDA approved OTC access for women of all ages to emergency contraception—the so-called “morning-after pill.” The most well-known emergency contraceptive is called “Plan B.” The fact that it is available
Article from Latest